| 摘要 |
The present invention relates to drug-ligand conjugates wherein the drug is linked to the ligand through a protein peptide linker and a connector, a process for the preparation of said conjugates, method of controlling the growth of undesirable cells, pharmaceutical compositions, and intermediates thereof. |
